MTD vs VVOS · P/E 27, rev $1.97B vs rev $10.3M
Mettler-Toledo International Inc (MTD) versus Vivos Therapeutics Inc (VVOS) — a side-by-side from cached financials, not a winner call.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Vivos Therapeutics Inc (VVOS) is a medical devices company listed on NASDAQ.
Latest reported MTD revenue for 2026-06-30 was $1.97B. Net income was $402.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Latest reported VVOS revenue for 2026-06-30 was $10.3M. Net income was -$13.2M. VVOS currently screens at market cap $7.1M.
MTD currently screens at market cap $23.20B and trailing P/E 26.9. VVOS currently screens at market cap $7.1M.
Not investment advice. Open the MTD and VVOS stock pages for the full models.
Not investment advice.